CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

HEALTHCARE SUPPLIER NEWS

Gilead, Sangamo strike $3B off-the-shelf CAR-T deal

Published: Thu, 22 Feb 2018 13:23:02 +0000
Gilead’s Kite has struck a $3 billion deal to access Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology. Kite will use the ZFN gene editing platform to create next-generation, off-the-shelf CAR-T therapies to cement its position as a long-term front-runner in the growing cell therapy space.

Santhera offers Raxone to U.S. DMD patients through expanded access program

Published: Thu, 22 Feb 2018 09:36:09 +0000
Santhera has suffered several regulatory setbacks around Raxone (idebenone) in Duchenne muscular dystrophy (DMD). In the absence of official approvals, the company is offering the drug for patients in the U.S. through an expanded access program operated by Clinigen.

GW cannabinoid drug fails midphase epilepsy trial

Published: Thu, 22 Feb 2018 09:14:35 +0000
GW Pharmaceuticals’ GWP42006 has failed to outperform placebo in a phase 2a focal seizure trial. The setback wiped 5% off GW’s stock and dented the prospects of the cannabidivarin candidate.
Displaying results 4-6 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top